Literature DB >> 32492700

HHEX promotes myeloid transformation in cooperation with mutant ASXL1.

Reina Takeda1, Shuhei Asada1,2, Sung-Joon Park3, Akihiko Yokoyama4, Hans Jiro Becker5, Akinori Kanai6, Valeria Visconte7, Courtney Hershberger8, Yasutaka Hayashi1,9, Taishi Yonezawa1, Moe Tamura1, Tsuyoshi Fukushima1, Yosuke Tanaka1, Tomofusa Fukuyama1, Akiko Matsumoto10, Satoshi Yamasaki10, Kenta Nakai3, Satoshi Yamazaki5,11, Toshiya Inaba6, Tatsuhiro Shibata10, Daichi Inoue9, Hiroaki Honda2, Susumu Goyama1, Jaroslaw P Maciejewski7, Toshio Kitamura1,9.   

Abstract

Additional sex combs-like 1 (ASXL1), an epigenetic modulator, is frequently mutated in myeloid neoplasms. Recent analyses of mutant ASXL1 conditional knockin (ASXL1-MT-KI) mice suggested that ASXL1-MT alone is insufficient for myeloid transformation. In our previous study, we used retrovirus-mediated insertional mutagenesis, which exhibited the susceptibility of ASXL1-MT-KI hematopoietic cells to transform into myeloid leukemia cells. In this screening, we identified the hematopoietically expressed homeobox (HHEX) gene as one of the common retrovirus integration sites. In this study, we investigated the potential cooperation between ASXL1-MT and HHEX in myeloid leukemogenesis. Expression of HHEX enhanced proliferation of ASXL1-MT-expressing HSPCs by inhibiting apoptosis and blocking differentiation, whereas it showed only modest effect in normal HSPCs. Moreover, ASXL1-MT and HHEX accelerated the development of RUNX1-ETO9a and FLT3-ITD leukemia. Conversely, HHEX depletion profoundly attenuated the colony-forming activity and leukemogenicity of ASXL1-MT-expressing leukemia cells. Mechanistically, we identified MYB and ETV5 as downstream targets for ASXL1-MT and HHEX by using transcriptome and chromatin immunoprecipitation-next-generation sequencing analyses. Moreover, we found that expression of ASXL1-MT enhanced the binding of HHEX to the promoter loci of MYB or ETV5 via reducing H2AK119ub. Depletion of MYB or ETV5 induced apoptosis or differentiation in ASXL1-MT-expressing leukemia cells, respectively. In addition, ectopic expression of MYB or ETV5 reversed the reduced colony-forming activity of HHEX-depleted ASXL1-MT-expressing leukemia cells. These findings indicate that the HHEX-MYB/ETV5 axis promotes myeloid transformation in ASXL1-mutated preleukemia cells.
© 2020 by The American Society of Hematology.

Entities:  

Year:  2020        PMID: 32492700     DOI: 10.1182/blood.2019004613

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  3 in total

1.  Oncogenic gene expression and epigenetic remodeling of cis-regulatory elements in ASXL1-mutant chronic myelomonocytic leukemia.

Authors:  Moritz Binder; Ryan M Carr; Terra L Lasho; Christy M Finke; Abhishek A Mangaonkar; Christopher L Pin; Kurt R Berger; Amelia Mazzone; Sandeep Potluri; Tamas Ordog; Keith D Robertson; David L Marks; Martin E Fernandez-Zapico; Alexandre Gaspar-Maia; Mrinal M Patnaik
Journal:  Nat Commun       Date:  2022-03-17       Impact factor: 17.694

Review 2.  ASXL1/2 mutations and myeloid malignancies.

Authors:  Edward A Medina; Caroline R Delma; Feng-Chun Yang
Journal:  J Hematol Oncol       Date:  2022-09-06       Impact factor: 23.168

3.  Bohring-Opitz syndrome caused by a novel ASXL1 mutation (c.3762delT) in an IVF baby: A case report.

Authors:  Dongbo Wang; Xin Yuan; Haichun Guo; Shuyuan Yan; Guohong Wang; Yanling Wang; Tuanmei Wang; Jun He; Xiangwen Peng
Journal:  Medicine (Baltimore)       Date:  2022-02-04       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.